Baxter Healthcare Corp. Friday updated U.S. hospital customers on its efforts to address a critical shortage of intravenous solutions since Hurricane Maria impacted its manufacturing facilities in Puerto Rico. Millions of units have been shipped to U.S. hospitals from Baxter facilities in other countries and all Baxter facilities on the island are now operating at pre-hurricane levels, the company said. While gaps in supply remain, in part due to high demand from a severe flu season, the company expects to return to more normal supply levels in coming weeks. 

Headline
The Health Sector Coordinating Council’s Cybersecurity Working Group has released a guide on third-party artificial intelligence risk and AI supply…
Headline
The White House April 2 issued a proclamation implementing additional tariffs on certain patented pharmaceutical products and ingredients. The order imposes a…
Headline
The AHA today submitted comments to the Centers for Medicare & Medicaid Services on an advanced notice of proposed rulemaking on potential options to…
Headline
The Administration for Strategic Preparedness and Response March 24 announced an investment to expand the domestic manufacturing of propofol and metoprolol.…
Headline
The Administration for Strategic Preparedness and Response announced March 5 that it will invest in the domestic production of thebaine, an ingredient…
Headline
The Supreme Court Feb. 20 ruled that the International Emergency Economic Powers Act does not authorize the imposition of global tariffs. The court held that…